01 3CELLTRION, Inc.
02 2Patheon Italia S.p.A.
03 1SAMSUNG BIOLOGICS Co., Ltd.
04 1Samsung BioLogics Co. LTD
01 1Infliximab
02 1Infliximab, License Holder Unspecified
03 2infliximab
04 3infliximab-dyyb
01 5South Korea
02 2U.S.A
NDC Package Code : 32228-001
Start Marketing Date : 2016-11-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/10mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 32228-001
Start Marketing Date : 2016-08-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/10mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 32228-002
Start Marketing Date : 2016-11-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (9kg/9kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68225-072
Start Marketing Date : 1998-08-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/10mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 68225-088
Start Marketing Date : 2017-07-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/10mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71124-0031
Start Marketing Date : 2023-07-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71124-0004
Start Marketing Date : 2018-09-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
We have 3 companies offering Inflectra
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
